Warning: UK E-liquids may Contain Dangerous Synthetic Drugs

Regulations by 2FIRSTS.ai
Feb.08.2024
Warning: UK E-liquids may Contain Dangerous Synthetic Drugs
Warning: Some e-liquids sold in the UK may contain illicit substances, including synthetic cannabinoids known as "spice."

Recently, health experts in Wales, UK issued a warning claiming that e-liquids being sold in the country may contain synthetic marijuana compounds known as "Spice". They argue that these illicit e-liquids have extremely potent medicinal effects and pose a danger to users who opt for counterfeit prescription drug e-cigarette products.

 

Some e-liquids consumed by UK consumers in their daily lives contain cannabis, CBD, or tetrahydrocannabinol (THC). Recently, WEDINOS, the only nationwide drug testing service in the UK, conducted tests and found that certain e-liquids being sold in the market also contain a potent synthetic drug known as synthetic cannabinoid receptor agonists (SCRAs), sometimes referred to as "spice." Based on these test results, the Welsh public health department has stated that some of these products being sold in the UK pose significant risks to consumers.

 

Synthetic cannabinoid receptor agonists (SCRAs) are a group of compounds associated with significant health issues, ranging from respiratory difficulties to psychiatric episodes. The latest data from WEDINOS, an organization, reveals that out of the 196 liquid samples submitted to them in 2023, 75 samples (almost one-third) contained one or more SCRA compounds.

 

These samples were purchased in the form of cannabis, CBD, or THC e-liquids. Among the number of hospitalizations due to illicit drugs, opioids are the most prevalent, followed by cannabis and synthetic cannabinoids such as Spice. Opioids also remain the most likely type of drug to be associated with drug-related deaths.

 

Experts from the agency have expressed concern over a significant increase in the number of counterfeit prescription drug samples they have received, which have been contaminated with potentially hazardous substances. They have also frequently detected the presence of benzodiazepines, a class of drugs commonly purchased as prescription medication, such as diazepam and hydrocodone.

 

These highly concentrated synthetic opioid medications can pose a threat to life, and there is a significant risk of overdosing. Last year, WEDINOS received 90 samples containing nitrous nitrogen drugs, with nearly 50% purchased under the mistaken belief of being an anti-anxiety medication called diazepam.

 

Professor Rick Lines, the Head of Drug Abuse at the Welsh Public Health Department, has highlighted the need to recognize the increased risk of medication overdose associated with high-concentration drugs. "Our concern is that people who purchase e-cigarettes online may not actually be receiving what they believe they are getting," he cautioned.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

AVOTX Clarifies Brand Positioning to 2Firsts: Independently Operated, No OEM/ODM Services
AVOTX Clarifies Brand Positioning to 2Firsts: Independently Operated, No OEM/ODM Services
AVOTX clarified to 2Firsts that it is an independently operated consumer brand and does not offer OEM/ODM services.
Jul.02
UK Study: Vape Shops in England Surge 1,200% in a Decade, Now Cover 97% of Regions
UK Study: Vape Shops in England Surge 1,200% in a Decade, Now Cover 97% of Regions
A new study reveals that the number of vape shops in England has surged nearly 1,200% over the past decade, with coverage expanding from just 33.8% of local authorities in 2014 to 97.2% in 2024.
May.26 by 2FIRSTS.ai
Russian NGO Calls for Halt of 2025 E-cigarette Expo, Citing Illegal Promotion of Nicotine Products
Russian NGO Calls for Halt of 2025 E-cigarette Expo, Citing Illegal Promotion of Nicotine Products
The Russian social movement organization "Сорок Сороков" has filed complaints with the prosecutors' offices in Moscow and Novosibirsk, demanding the ban of the 2025 E-cigarette Expo (Vape Club Show). The complainants argue that the event constitutes illegal promotion of nicotine products and sets a bad example for young people.
May.07 by 2FIRSTS.ai
2Firsts Convenes 2025 Insight Session on Dual Challenges of U.S. NGP Regulation & Tariff Trends/ Closed-Door Seminar on Nicotine Pouch PMTA Technical Analysis
2Firsts Convenes 2025 Insight Session on Dual Challenges of U.S. NGP Regulation & Tariff Trends/ Closed-Door Seminar on Nicotine Pouch PMTA Technical Analysis
2Firsts successfully hosted a seminar in Shenzhen titled "Eye of the Storm: 2025 Insight Session on Dual Challenges of U.S. NGP Regulation & Tariff Trends/ Closed-Door Seminar on Nicotine Pouch PMTA Technical Analysis." The event explored compliance pathways for nicotine pouches and upcoming U.S. regulatory and tariff trends, offering practical insights for industry stakeholders.
May.13 by 2FIRSTS.ai
Legal Insight: Chinese E-cigarette Export to Australia Sparks Lawsuit Amid Ban, Logistics Firm Faces Major Claims
Legal Insight: Chinese E-cigarette Export to Australia Sparks Lawsuit Amid Ban, Logistics Firm Faces Major Claims
A Chinese e-cigarette shipment to Australia led to a lawsuit after the products were allegedly illegal and lost. The case highlights gray clearance risks and evidentiary challenges, potentially setting a precedent in illicit vape trade disputes.
Jun.20
Smoore Announces Equity Incentive Plan: Grants Over 4M Shares to 49 Employees, Valued at Over HK$54.14M
Smoore Announces Equity Incentive Plan: Grants Over 4M Shares to 49 Employees, Valued at Over HK$54.14M
Smoore International has granted a total of 4.004 million shares to 49 employees under its share award and option plans. The package includes 1.614 million awarded shares and 2.39 million options exercisable at HK$13.52 per share, with a total value of HK$54.14 million.
May.08 by 2FIRSTS.ai